Cargando…
Advances of Epigenetic Biomarkers and Epigenome Editing for Early Diagnosis in Breast Cancer
Epigenetic modifications are known to regulate cell phenotype during cancer progression, including breast cancer. Unlike genetic alterations, changes in the epigenome are reversible, thus potentially reversed by epi-drugs. Breast cancer, the most common cause of cancer death worldwide in women, enco...
Autores principales: | Sarvari, Pourya, Sarvari, Pouya, Ramírez-Díaz, Ivonne, Mahjoubi, Frouzandeh, Rubio, Karla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9455804/ https://www.ncbi.nlm.nih.gov/pubmed/36076918 http://dx.doi.org/10.3390/ijms23179521 |
Ejemplares similares
-
Epigenetic Regulation in Exposome-Induced Tumorigenesis: Emerging Roles of ncRNAs
por: Olmedo-Suárez, Miguel Ángel, et al.
Publicado: (2022) -
Epigenetic Mechanisms in Parenchymal Lung Diseases: Bystanders or Therapeutic Targets?
por: Avci, Edibe, et al.
Publicado: (2022) -
Editorial: Therapeutic targeting of splicing variants in cancer
por: Sarvari, Pouya, et al.
Publicado: (2023) -
Expression of LRP Gene in Breast Cancer Patients Correlated with MRP1 as Two Independent Predictive Biomarkers in Breast Cancer
por: Taheri, Mohsen, et al.
Publicado: (2018) -
AKAP4, SPAG9 and NY-ESO-1 in Iranian Colorectal Cancer Patients as Probable Diagnostic and Prognostic Biomarkers
por: Koudehi, Ameneh Tavakoli, et al.
Publicado: (2018)